Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Dividends Aren't Enough: Biotech
Motley Fool
Fri, 08/20/10 - 12:48 pm
Tags:
biotech, Gilead Sciences, Amgen, Genzyme, Biogen Idec, Dendreon
Generic Risk For Gilead's Hepsera
Yahoo/Zacks.com
Fri, 08/20/10 - 10:56 am
Tags:
Gilead Sciences, Hepsera, generics, Bristol-Myers Squibb, Merck, hepatitis B
Gilead: Analysts' Upgrades, Downgrades
TheStreet.com
Mon, 08/16/10 - 10:05 am
Tags:
downgrades, upgrades, Gilead Sciences
Is Gilead Sciences Growing Foolishly?
Motley Fool
Fri, 08/13/10 - 09:22 am
Tags:
Gilead Sciences, Merck, Genzyme
Gilead facility may get FDA warning letter
Bizjournals.com
Wed, 08/11/10 - 11:12 am
Tags:
FDA, warnings, Gilead Sciences
Analysis: HIV generics under threat from tighter patenting rules
PlusNews Global
Mon, 08/2/10 - 10:19 am
Tags:
generics, HIV, AIDS, India, Aspen, Gilead Sciences
Big Biotech: End of an Era
Seeking Alpha
Wed, 07/28/10 - 10:17 am
Tags:
Alexion, Amgen, Amylin, Biogen Idec, Biomarin, Celgene, Genentech, Dendreon, Genzyme, Gilead Sciences, GSK, Roche, Human Genome Sciences, Vertex Pharmaceuticals, Sanofi
Gilead to Repurchase $1 Billion in Stock
TheStreet.com
Mon, 07/26/10 - 01:22 pm
Tags:
Gilead Sciences, share repurchase
Biotech Stock Mailbag: Exact Sciences
TheStreet.com
Fri, 07/23/10 - 07:16 am
Tags:
EXACT Sciences, MannKind, Gilead Sciences, Somaxon, JNJ, Allos, Cell Therapeutics
Gilead Holding Up on Exhaustion of Negativity
Seeking Alpha
Thu, 07/22/10 - 09:27 am
Tags:
Gilead Sciences
15% Revenue Growth Is Good for Pfizer, but Not Gilead
Motley Fool
Thu, 07/22/10 - 08:43 am
Tags:
Pfizer, Gilead Sciences, earnings, JNJ, Bristol-Myers Squibb, Merck
Gilead Drops on Q2 Miss; Some HIV Drugs Decline
Bizjournals.com
Wed, 07/21/10 - 08:01 am
Tags:
Gilead Sciences, earnings
Down to the Bone: Is an HIV Drug's Link to Fractures Underplayed?
BNET Pharma
Tue, 07/20/10 - 08:25 am
Tags:
Viread, Gilead Sciences, HIV
Abbott Labs Loves Merck More Than Gilead
Motley Fool
Mon, 07/19/10 - 06:46 pm
Tags:
Abbott Laboratories, Merck, Gilead Sciences, Truvada, HIV, Kaletra, Inverness Medical
FACTBOX-Gilead dominates HIV/AIDS drugs market
Reuters
Mon, 07/19/10 - 11:50 am
Tags:
Gilead Sciences, HIV, AIDS
Gilead Sciences: Time to Take Another Look
Seeking Alpha
Sun, 07/18/10 - 07:44 am
Tags:
Gilead Sciences
Gilead shares fall on pipeline concerns
MarketWatch
Sat, 07/17/10 - 09:49 am
Tags:
Gilead Sciences
Gilead Sciences: Undervalued
Seeking Alpha
Mon, 07/12/10 - 02:34 pm
Tags:
Gilead Sciences, Merck, JNJ, Vertex Pharmaceuticals
Biotech Milestones to Watch in Q3: Obesity Drugs, Genetic Testing and More
BNET Pharma
Wed, 07/7/10 - 09:36 am
Tags:
Vivus, Qnexa, Myriad, Genomic Health, NicOx, naproxcinod, Savient, Krystexxa, Novartis, Gilenia, Seattle Genetics, Gilead Sciences, Chelsea Therapeutics, Eisai
Sanofi-Aventis: Rumored $20 Billion Swoop Could Be About Diversification
Seeking Alpha
Tue, 07/6/10 - 09:16 am
Tags:
Sanofi, diversification, M&A, Biogen Idec, Genzyme, Covidien, Celgene, Shire, Gilead Sciences, Eli Lilly, Bristol-Myers Squibb, Hospira, Cardinal Health

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.